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Background
“Elite” controllers are HIV-1 infected patients who spon-
taneously maintain undetectable levels of  HIV-1 viremia.
The Identification of unique immunological characteris-
tics in this specific patient population is a premier oppor-
tunity for determining components of immune
protection against HIV-1. 
Methods
Functional properties of freshly isolated myeloid den-
dritic cells were analyzed in mixed lymphocyte reactions.
Surface expression of costimulatory molecules and myelo-
monocytic receptors was analyzed by multiparameter
flow cytometry. Targeted si-RNA mediated gene knock-
out was used to determine the impact of specific func-
tional effects mediated by regulatory myelomonocytic
receptors. Assays were performed in elite controllers
(n=11) and HIV-1 progressors (n=11) or healthy HIV-1
uninfected persons (n=12) as reference cohorts. 
Results
In comparison to both HIV-1 progressors or healthy per-
sons, dendritic cells from “elite” controllers had signifi-
cantly higher ability to expand allogeneic CD4+ and
CD8+ T cells. Costimulatory molecules (CD80, CD86,
CD40, CD83) were expressed at higher levels in HIV-1
progressors, while no significant difference was observed
between controllers and HIV-1 negative persons. To deter-
mine underlying reasons for the increased functional
activity of mDCs in controllers, we assessed the expression
of regulatory dendritic cells receptors that can critically
modulate dendritic cell function. The receptor ILT2 and
ILT5 were significantly higher expressed on mDC in con-
trollers, as opposed to either progressors of HIV-1 nega-
tive persons.  Si-RNA mediated knock out of ILT2 or ILT5
led to significant reduction of the functional activity of
dendritic cells, indicating that it has a critical stimulatory
effect on these cells.
Conclusion
HIV-1 “elite” controllers have myeloid dendritic cells with
a uniquely increased allostimulatory activity. This extraor-
dinary functional profile is mediated by signaling through
ILT2 and ILT5, which are uniquely upregulated on these
cells. Manipulation of dendritic cell function might thus
represent a promising strategy for immunological
approaches to treatment and prevention of HIV-1 infec-
tion. 
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